Talk:2C-D/Archive 1: Difference between revisions
>Oskykins |
>Oskykins m Text replacement - "doses or using it very sparingly" to "doses and using it very sparingly" |
||
(43 intermediate revisions by 5 users not shown) | |||
Line 1: | Line 1: | ||
{{Archive for converted wikitext talk page|from=Talk:2C-D|date=2015-07-23}} | |||
{{Stub}} | |||
{| class="wikitable" align="right" | {| class="wikitable" align="right" | ||
! colspan="2" style="background:lightblue | ! colspan="2" style="background:lightblue;font-size:10pt" | 2C-D | ||
|- | |- | ||
| colspan="2" style="text-align:center;font-size:7pt" | [[Image: | | colspan="2" style="text-align:center;font-size:7pt" | [[Image:2C-D2.png|noframe|257px]]<br /> | ||
|- | |- | ||
| colspan="2" style="background:lightblue;text-align:center;font-size:9pt" | '''Dosage (oral)''' | | colspan="2" style="background:lightblue;text-align:center;font-size:9pt" | '''Dosage (oral)''' | ||
Line 27: | Line 31: | ||
|} | |} | ||
'''2C-D''' ('''2,5-dimethoxy-4-methylphenethylamine''') is a synthetically produced [[psychoactive]] drug usually sold by online research chemical vendors. The substance itself is classed as a psychedelic [[Phenethylamines|phenethylamine]] of the [[2C-x]] family and was first synthesized in 1970 by a team from the Texas Research Institute of Mental Sciences[ | '''2C-D''' ('''2,5-dimethoxy-4-methylphenethylamine''') is a synthetically produced [[psychoactive]] drug usually sold by online [[research chemical]] vendors. The substance itself is classed as a psychedelic [[Phenethylamines|phenethylamine]] of the [[2C-x]] family and was first synthesized in 1970 by a team from the Texas Research Institute of Mental Sciences.<ref>Amphetamine analogs. II. Methylated phenethylamines | http://www.pubs.acs.org/doi/abs/10.1021/jm00295a034</ref> It was described and investigated by humans in Shulgin’s 1991 book [[PiHKAL]]: A Chemical Love Story. In his book, Shulgin lists the dosage range as being from 20 to 60 mg with many people recommending higher doses. | ||
The drug is used recreationally for its [[psychedelic]] and [[entactogenic]] effects. Shulgin himself referred to this substance as a “pharmacological tofu,” meaning that when mixed with other substances, it can extend or potentiate their effects without coloring the experience too much. 2C-D is generally taken orally, though it may be insufflated. Insufflating tends to cause intense pain, however, and the dosage level is usually much lower. Lower doses (generally 10 mg or less) of 2C-D have been explored as a potential nootropic, albeit with mixed results. | |||
=Chemistry= | =Chemistry= | ||
Line 41: | Line 45: | ||
*'''[[Physical effects: Blank|Blank]]''' - | *'''[[Physical effects: Blank|Blank]]''' - | ||
*'''[[ | *'''[[Nausea|Nausea]]''' - Mild to extreme nausea is reported when consumed in moderate to high dosages and either passes once the tripper has vomited or gradually fades by itself as the peak sets in. | ||
==[[Cognitive effects - Psychedelics|Cognitive effects]]== | ==[[Cognitive effects - Psychedelics|Cognitive effects]]== | ||
Line 54: | Line 58: | ||
===[[Visual effects - Psychedelics#Enhancements|Enhancements]]=== | ===[[Visual effects - Psychedelics#Enhancements|Enhancements]]=== | ||
2C-D presents a full and complete array of possible visual enhancements which generally includes: | 2C-D presents a full and complete array of possible visual enhancements which generally includes: | ||
*'''[[Visual | *'''[[Visual acuity enhancement|Visual acuity enhancement]]''' | ||
*'''[[ | *'''[[Colour enhancement|Colour enhancement]]''' | ||
*'''[[ | *'''[[Pattern recognition enhancement|Pattern recognition enhancement]]''' | ||
===[[Visual effects - Psychedelics#Distortions|Distortions]]=== | ===[[Visual effects - Psychedelics#Distortions|Distortions]]=== | ||
Line 67: | Line 71: | ||
===[[Visual effects - Psychedelics#Hallucinatory States|Hallucinatory states]]=== | ===[[Visual effects - Psychedelics#Hallucinatory States|Hallucinatory states]]=== | ||
*'''[[ | *'''[[External hallucinations|External hallucinations]]''' | ||
*'''[[ | *'''[[Internal hallucinations|Internal hallucinations]]''' | ||
=Toxicity and | =Toxicity and harm potential= | ||
===Lethal | ===Lethal dosage=== | ||
The toxicity and long term health effects of recreational 2C-D use | The toxicity and long-term health effects of recreational 2C-D use have not been studied in any scientific context and the exact toxic dosage is unknown. This is because 2C-D is a [[research chemical]] with very little history of human usage. Anecdotal evidence from people who have tried 2C-D within the psychonaut community suggests that there are no negative health effects attributed to simply trying the drug by itself at low to moderate doses and using it very sparingly (but nothing can be completely guaranteed). [https://www.google.com/ Independent research] should always be done to ensure that a combination of two or more substances is safe before consumption. | ||
===Tolerance and | It is strongly recommended that one use [[responsible use|harm reduction practices]] when using this drug. | ||
===Tolerance and addiction potential=== | |||
2C-D does not seem to be physically addictive and many users experience a self-regulating quality. There seems to be a tolerance build up when used consecutively multiple days in a row which could lead to a diminished experience. However, this effect is nearly non-existent when spaced 5-7 days apart. | 2C-D does not seem to be physically addictive and many users experience a self-regulating quality. There seems to be a tolerance build up when used consecutively multiple days in a row which could lead to a diminished experience. However, this effect is nearly non-existent when spaced 5-7 days apart. | ||
=Legal | =Legal issues= | ||
*'''Canada:''' | *'''Canada:''' | ||
*'''United Kingdom:''' | *'''United Kingdom:''' | ||
*'''Denmark:''' 2C-D has been added to the list of Schedule B controlled substances.<ref>Bekendtgørelse om euforiserende stoffer | https://www.retsinformation.dk/Forms/R0710.aspx?id=137169</ref> | |||
*'''Sweden:''' 2C-D is classified as "health hazard" as of Mar 1, 2005 in their regulation '''SFS 2005:26''', making it illegal to sell or possess.<ref>Svensk författningssamling | http://www.notisum.se/rnp/sls/sfs/20050026.pdf</ref> | |||
*'''United States:''' 2C-D became a Schedule I Controlled Substance in the United States as of July 9, 2012, with the signing of [http://thomas.loc.gov/cgi-bin/query/z?c112:S.3187: S. 3187] into law by President Barack Obama.<ref>Bill Text Versions 112th Congress (2011-2012) S.3187 | http://thomas.loc.gov/cgi-bin/query/z?c112:S.3187:</ref> | |||
=See | =See also= | ||
*[[ | *[[Psychoactive substance index|Specific Substances]] | ||
*[[Psychedelics]] | |||
*[[Phenethylamines]] | |||
*[[2C-x]] | |||
*[http://en.wikipedia.org/wiki/2C-D 2C-D (Wikipedia)] | *[http://en.wikipedia.org/wiki/2C-D 2C-D (Wikipedia)] | ||
*[https://www.erowid.org/chemicals/2cd/2cd.shtml 2C-D (Erowid)] | *[https://www.erowid.org/chemicals/2cd/2cd.shtml 2C-D (Erowid)] |